Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.

Ann Surg. 2013 May;257(5):894-9. doi: 10.1097/SLA.0b013e31826b8603.

PMID:
23579541
2.

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J.

Surg Endosc. 2012 Aug;26(8):2231-9. doi: 10.1007/s00464-012-2166-y.

PMID:
22302537
3.

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

Morínigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J.

Obes Surg. 2006 Dec;16(12):1594-601.

PMID:
17217635
4.

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.

Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122-31. doi: 10.1152/ajpendo.00073.2012. Epub 2012 Apr 24.

5.

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.

Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I, Morínigo R, Lacy AM.

J Clin Endocrinol Metab. 2009 Mar;94(3):884-91. doi: 10.1210/jc.2008-1620. Epub 2008 Dec 23.

PMID:
19106269
6.

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J.

Ann Surg. 2012 Dec;256(6):1023-9. doi: 10.1097/SLA.0b013e318262ee6b.

PMID:
22968072
7.

GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?

Dar MS, Chapman WH 3rd, Pender JR, Drake AJ 3rd, O'Brien K, Tanenberg RJ, Dohm GL, Pories WJ.

Obes Surg. 2012 Jul;22(7):1077-83. doi: 10.1007/s11695-012-0624-1.

PMID:
22419108
8.

Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.

Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G.

Ann Surg. 2013 Mar;257(3):462-8. doi: 10.1097/SLA.0b013e318269cf5c.

PMID:
23388352
9.

Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.

Elahi D, Galiatsatos P, Rabiee A, Salas-Carrillo R, Vakilipour A, Carlson OD, Angeli FS, Shannon RP, Egan JM, Andersen DK.

Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1028-39. doi: 10.1016/j.soard.2014.07.011. Epub 2014 Aug 15.

PMID:
25443077
10.

Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.

Umeda LM, Silva EA, Carneiro G, Arasaki CH, Geloneze B, Zanella MT.

Obes Surg. 2011 Jul;21(7):896-901. doi: 10.1007/s11695-011-0412-3.

PMID:
21559794
11.

Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile.

Jiménez A, Ceriello A, Casamitjana R, Flores L, Viaplana-Masclans J, Vidal J.

Ann Surg. 2015 Feb;261(2):316-22. doi: 10.1097/SLA.0000000000000586.

PMID:
25569030
12.

GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes.

Jiménez A, Mari A, Casamitjana R, Lacy A, Ferrannini E, Vidal J.

Diabetes. 2014 Oct;63(10):3372-7. doi: 10.2337/db14-0357. Epub 2014 May 21.

13.

The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.

Kim MK, Lee HC, Lee SH, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH.

Diabetes Metab Res Rev. 2012 Jul;28(5):439-46. doi: 10.1002/dmrr.2297. Epub 2012 Mar 8.

PMID:
22407971
14.
15.

Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL.

Am Surg. 2004 Jan;70(1):1-4; discussion 4-5.

PMID:
14964537
16.

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery.

Jiménez A, Casamitjana R, Viaplana-Masclans J, Lacy A, Vidal J.

Diabetes Care. 2013 Jul;36(7):2062-9. doi: 10.2337/dc12-1535. Epub 2013 Jan 28.

17.

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S.

Obes Surg. 2012 Jul;22(7):1084-96. doi: 10.1007/s11695-012-0621-4.

PMID:
22359255
18.

Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.

Chronaiou A, Tsoli M, Kehagias I, Leotsinidis M, Kalfarentzos F, Alexandrides TK.

Obes Surg. 2012 Nov;22(11):1761-70. doi: 10.1007/s11695-012-0738-5. Erratum in: Obes Surg. 2013 Mar;23(3):425.

PMID:
22911148
19.

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.

Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E.

J Clin Endocrinol Metab. 2013 Nov;98(11):4391-9. doi: 10.1210/jc.2013-2538. Epub 2013 Sep 20.

PMID:
24057293
20.

Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.

Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK.

Diabetes. 2003 May;52(5):1098-103.

Supplemental Content

Support Center